Mangrove derived Streptomyces sp. MUM265 as a potential source of antioxidant and anticolon-cancer agents.
Loh Teng-Hern TanKok-Gan ChanPriyia PusparajahWai-Fong YinTahir Mehmood KhanLearn-Han LeeBey Hing GohPublished in: BMC microbiology (2019)
These findings indicate that mangrove derived Streptomyces sp. MUM265 represents a valuable bioresource of bioactive compounds for the future development of chemopreventive agents, with particular promise suggested for treatment of colon cancer.